The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Pfizer's solo Xeljanz can't match AbbVie's Humira in big RA head-to-head miss

Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top

AbbVie's Q4 sales miss the mark as cancer, hep C meds lag

Amgen hikes prices by single digits, with Enbrel matching AbbVie's Humira boost

Bad news for biosim makers: FDA sets 'high bar' in interchangeability guidance

Sanofi's Brandicourt announces at JPM that plant issues leading to CRL for RA drug have been fixed

Humira finishes year as strong as it started, grabbing No. 1 TV spender spot for December

Top 20 pharma brands dropped more than $2B on national TV ads last year

BMS' Opdivo jumps back into pharma's top 3 TV ad spenders for November

Momenta ramps up biosim pressure on AbbVie's Humira with phase 3 psoriasis win